AMGN Competitors & Alternatives
Compare Amgen Inc with similar stocks in the same industry
Drug Manufacturers - General
AMGN
Main Stock$347.01
Tradestie Score
64
Market Cap
$160.70B
P/E Ratio
24.0
Revenue Growth
0.1%
Analyst Upside
+1.7%
Top Competitors
16 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$47.42
|
$262.92B | 10.9 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$181.02
|
$261.56B | 27.2 | 51 | Compare |
|
NVS
Novartis AG
|
$153.38
|
$254.99B | 21.3 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.60
|
$225.13B | 32.5 | 59 | Compare |
|
PFE
Pfizer Inc.
|
$24.72
|
$154.70B | 19.1 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$125.05
|
$137.92B | 17.0 | 56 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.60
|
$121.27B | 18.4 | 57 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$55.53
|
$96.54B | 15.3 | 56 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$52.07
|
$91.59B | 13.5 | 57 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$197.19
|
$22.61B | 21.5 | 63 | Compare |
More AMGN Analysis
Data updated: Jun 23, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
16 stocks in this industry